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These findings were presented in part as a poster at the American Thoracic Society International Conference, May 19 to 24, in Washington, DC.

Clinical PerspectiveWhat Is New?Cardiovascular dysfunction in sepsis is associated with worse outcomes; however, there are limited data on the epidemiology and outcomes of Takotsubo cardiomyopathy in severe sepsis.What Are the Clinical Implications?In this 7‐year study, using a nationally representative database, we highlight the incidence and predictors of Takotsubo cardiomyopathy in severe sepsis and demonstrate that Takotsubo cardiomyopathy is associated with lower in‐hospital mortality.

Introduction {#jah33510-sec-0008}
============

Takotsubo cardiomyopathy (TTC) was first described in 1990 and has been increasingly recognized in clinical practice.[1](#jah33510-bib-0001){ref-type="ref"} Labeled variably as apical‐ballooning syndrome, stress cardiomyopathy, and broken‐heart syndrome, TTC is characterized by transient regional left ventricular systolic dysfunction without obstructive coronary artery disease, precipitated by emotional and physical triggers.[1](#jah33510-bib-0001){ref-type="ref"}, [2](#jah33510-bib-0002){ref-type="ref"} It is diagnosed most commonly in postmenopausal females, though it does occur in young women and males.[1](#jah33510-bib-0001){ref-type="ref"}, [3](#jah33510-bib-0003){ref-type="ref"} Postulated pathogenesis includes myocardial stunning, catecholamine toxicity, and impaired myocyte metabolism.[4](#jah33510-bib-0004){ref-type="ref"} Among the many proposed diagnostic criteria, TTC is most commonly diagnosed using the Mayo Clinic criteria: (1) transient hypokinesis, akinesias or dyskinesia of the left ventricular midsegments with or without apical involvement; (2) absence of obstructive coronary artery disease or angiographic evidence of acute plaque rupture; (3) new ECG abnormalities or modest elevation in cardiac troponins; and (4) absence of pheochromocytoma or myocarditis.[5](#jah33510-bib-0005){ref-type="ref"}

Patients admitted to intensive care units are subject to severe physical/emotional stress and catecholamine surges, which can potentially trigger TTC. Sepsis continues to be a leading cause of mortality and morbidity in intensive care units in the United States.[6](#jah33510-bib-0006){ref-type="ref"} Multiorgan dysfunction is observed in up to 45% of patients presenting with sepsis and is associated with worse short‐term outcomes and long‐term organ dysfunction.[7](#jah33510-bib-0007){ref-type="ref"}, [8](#jah33510-bib-0008){ref-type="ref"}, [9](#jah33510-bib-0009){ref-type="ref"} Cardiovascular dysfunction in sepsis can manifest as septic cardiomyopathy, TTC, refractory shock, and myocardial injury, resulting in worse mortality and morbidity.[10](#jah33510-bib-0010){ref-type="ref"}, [11](#jah33510-bib-0011){ref-type="ref"}, [12](#jah33510-bib-0012){ref-type="ref"}, [13](#jah33510-bib-0013){ref-type="ref"}, [14](#jah33510-bib-0014){ref-type="ref"} Despite extensive data on septic cardiomyopathy, there are limited large‐scale epidemiological data on TTC in patients with severe sepsis.[1](#jah33510-bib-0001){ref-type="ref"}, [15](#jah33510-bib-0015){ref-type="ref"} The aim of this study was to evaluate the trends and outcomes of TTC in patients with severe sepsis from a large US cohort.

Material and Methods {#jah33510-sec-0009}
====================

The data used for this study are publicly available with the Healthcare Cost and Utilization Project (HCUP)/National (Nationwide) Inpatient Sample (NIS).[16](#jah33510-bib-0016){ref-type="ref"} The data, analytical methods, and study materials have been made available to other researchers for purposes of reproducing the results or replicating the procedure. Please refer to Tables [1](#jah33510-tbl-0001){ref-type="table"} and [2](#jah33510-tbl-0002){ref-type="table"} for detailed *International Classification of Diseases*,*Ninth Revision*,*Clinical Modification* (*ICD‐9‐CM*) codes used in this study.

###### 

*ICD‐9‐CM* Codes Used to Identify Admissions With Severe Sepsis

  Diagnosis                           *ICD‐9‐CM* Code
  ----------------------------------- ------------------------------------------------------------------------------------------------------------------
  Septicemia                          038.0, 038.10, 038.11, 038.19, 038.2, 038.3, 038.4, 038.40, 038.41, 038.42, 038.43, 038.44, 038.49, 038.8, 038.9
  Bacteremia                          790.7
  Disseminated fungal infection       117.9
  Disseminated candidal infection     112.5
  Fungal endocarditis                 115.04, 115.14, 115.94
  Candidal endocarditis               112.81
  Candidal meningitis                 112.83
  Salmonella septicemia               003.1
  Salmonella meningitis               003.21
  Meningococcal septicemia            036.2
  Waterhouse--Friderichsen syndrome   036.3
  Meningococcal meningitis            036.0
  Meningococcal encephalitis          036.1
  Meningococcal endocarditis          036.42
  Septicemic plague                   020.2
  Anthrax septicemia                  022.3
  Gonococcemia                        098.89
  Gonococcal endocarditis             098.84
  Gonococcal meningitis               098.82
  Severe sepsis                       995.92
  Septic shock                        785.52

*ICD‐9‐CM* indicates *International Classification of Diseases*,*Ninth Revision*,*Clinical Modification*.

###### 

*ICD‐9‐CM* Codes Used for Acute Organ Dysfunction

  Organ Failure                   *ICD‐9‐CM* Code                                                                                                                                                            Description
  ------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------
  Respiratory                     518.81                                                                                                                                                                     Acute respiratory failure
  518.82                          Other pulmonary insufficiency, not elsewhere classified. Includes---acute respiratory distress, acute respiratory insufficiency, adult respiratory distress syndrome NEC   
  518.85                          Acute respiratory distress syndrome after shock or trauma                                                                                                                  
  786.09                          Respiratory distress NOS                                                                                                                                                   
  799.1                           Respiratory arrest                                                                                                                                                         
  96.7, 96.70, 96.71, 96.72       Ventilator management                                                                                                                                                      
  Cardiovascular                  785.5                                                                                                                                                                      Shock without mention of trauma
  785.50                          Shock unspecified                                                                                                                                                          
  785.59                          Other shock without trauma (includes hypovolemic shock)                                                                                                                    
  785.51                          Cardiogenic shock                                                                                                                                                          
  785.52                          Septic shock                                                                                                                                                               
  458.8, 458.9, 796.3             Hypotension NOS                                                                                                                                                            
  Renal                           584, 584.5, 584.6, 584.7, 584.8, 584.9                                                                                                                                     Acute kidney injury
  Hepatic                         570                                                                                                                                                                        Acute hepatic failure or necrosis
  572.2                           Hepatic encephalopathy                                                                                                                                                     
  573.3                           Hepatitis unspecified                                                                                                                                                      
  573.4                           Hepatic infarction                                                                                                                                                         
  Hematologic                     286.6                                                                                                                                                                      Defibrination syndrome
  286.7                           Acquired coagulation factor deficiency                                                                                                                                     
  286.9                           Other coagulation defect                                                                                                                                                   
  287.4, 287.5                    Thrombocytopenia---secondary or unspecified                                                                                                                                
  Metabolic                       276.2                                                                                                                                                                      Acidosis---metabolic or lactic
  Neurologic                      293, 293.0, 293.1, 293.8, 293.81, 293.82, 293.83, 293.84, 293.89, 293.9                                                                                                    Transient organic psychotic conditions
  348.1                           Anoxic brain injury                                                                                                                                                        
  348.3, 348.30, 348.31, 348.39   Acute encephalopathy                                                                                                                                                       
  780.01                          Coma                                                                                                                                                                       
  780.09                          Altered consciousness---unspecified                                                                                                                                        
  89.14                           Electroencephalogram                                                                                                                                                       

*ICD‐9‐CM* indicates *International Classification of Diseases*,*Ninth Revision*,*Clinical Modification*; NEC, not elsewhere classified; NOS, not otherwise specified.

Study Design and Database {#jah33510-sec-0010}
-------------------------

The Healthcare Cost and Utilization Project/NIS was used to obtain data for this study duration of 2007--2013. The NIS, the largest all‐payer inpatient care database publicly available in the United States, provides data for a 20% stratified sample of the US community hospitals.[17](#jah33510-bib-0017){ref-type="ref"} Information regarding each discharge includes patient demographics, primary payer, hospital characteristics, principal diagnosis, up to 24 additional secondary diagnoses, and procedural diagnoses. No institutional review board approval was sought because of the publically available de‐identified data set used in this research.

Study Population, Variables, and Outcomes {#jah33510-sec-0011}
-----------------------------------------

All hospitalizations for severe sepsis as the primary diagnosis in patients aged ≥20 years were included in this study. Severe sepsis was defined using the *ICD‐9‐CM* codes for severe sepsis or septic shock, septicemia, bacteremia, or fungemia with at least 1 organ dysfunction (Tables [1](#jah33510-tbl-0001){ref-type="table"} and [2](#jah33510-tbl-0002){ref-type="table"}).[18](#jah33510-bib-0018){ref-type="ref"}, [19](#jah33510-bib-0019){ref-type="ref"}, [20](#jah33510-bib-0020){ref-type="ref"}, [21](#jah33510-bib-0021){ref-type="ref"} This definition of severe sepsis is consistent with the 2001 American College of Chest Physicians/Society of Critical Care Medicine consensus criteria for severe sepsis: consequent organ dysfunction, hypoperfusion, or hypotension.[22](#jah33510-bib-0022){ref-type="ref"} Using previously validated algorithms for microbiological cultures, septic patients were classified into "culture‐positive" and "culture‐negative" sepsis.[21](#jah33510-bib-0021){ref-type="ref"} Development of TTC in this cohort of severe sepsis was identified using *ICD‐9‐CM* code 429.83. Demographic characteristics (age, sex, and race), hospital characteristics (teaching status and location, bed size, and region), and primary payer associated with each discharge were identified from the NIS database. Hospitals were divided into tertiles based on the annual volume of severe sepsis discharges (\<178, 178--484, or \>484 per year). Deyo\'s modification of Charlson Comorbidity Index was used to identify burden of comorbid diseases.[23](#jah33510-bib-0023){ref-type="ref"} Use of mechanical ventilation was identified using *ICD‐9‐CM* procedure codes 96.70, 96.71, and 96.72.

The primary outcomes of interest were frequency and trends of TTC and its associated in‐hospital mortality. Secondary outcomes included length of stay, hospitalization costs, and discharge disposition in patients with versus without TTC in severe sepsis. Additional secondary outcomes included predictors of TTC and predictors of mortality in patients with TTC in hospital admissions for severe sepsis.

Statistical Analysis {#jah33510-sec-0012}
--------------------

As recommended by the Healthcare Cost and Utilization Project/NIS, survey procedures using discharge weights provided with the NIS database were used to generate national estimates.[24](#jah33510-bib-0024){ref-type="ref"} Chi‐square and *t* tests were used to compare categorical and continuous variables, respectively. Linear regression was used to analyze trends over time. An a priori multivariable regression model was used to assess whether TTC is an independent predictor of in‐hospital mortality in patients with severe sepsis. The model was adjusted for patient age, sex, race, primary payer, Charlson Comorbidity Index, hospital bed size, volume, region, location and teaching status, individual organ dysfunction, use of mechanical ventilation, presence of septic shock, and year of admission. We also performed a supplemental analysis where we used restricted cubic spline transformations of age and year of admission using 5 knots to model the nonlinear relationship with mortality. Because TTC is observed more often in females and in middle‐aged patients,[1](#jah33510-bib-0001){ref-type="ref"} we also evaluated for an interaction term between sex and age with the presence of TTC in the model to see whether there was a differential effect of sex/age on in‐hospital mortality attributed to TTC.

All variables had \<1% missing values, except race that was missing in 11.1% of the observations. Because patients with and without TTC differed in their baseline characteristics, we performed another sensitivity analysis by using propensity matching for baseline characteristics between the 2 cohorts. We used a multivariable logistic regression to generate a propensity score with TTC as the dependent variable. We then used 1:1 nearest neighbor matching with 0.01 calipers and without replacement to match patients with TTC to those without. The propensity‐matched sample had standardized differences \<10% for all baseline characteristics (Figure [1](#jah33510-fig-0001){ref-type="fig"}). The final matched cohort had 1945 pairs with a total of 3890 observations. We then used the propensity‐matched sample for logistic regression to assess the impact of TTC on in‐hospital mortality in patients with severe sepsis. A sandwich covariance estimator was used to adjust for correlation between matched pairs in this logistic regression model. All statistical analyses were performed using STATA software (version 14.0; StataCorp LP, College Station, TX).

![Propensity‐matched sample of patients with severe sepsis with and without Takotsubo cardiomyopathy. All baseline characteristics of demographics, acute organ dysfunction, and hospital characteristics after propensity matching show \<10% standardized differences for the cohorts with and without Takotsubo cardiomyopathy in severe sepsis.](JAH3-7-e009160-g001){#jah33510-fig-0001}

Results {#jah33510-sec-0013}
=======

In the period from 2007 to 2013, there were an estimated 7.1 million (95% confidence interval \[CI\], 6.9--7.3) admissions with severe sepsis in this stratified sample from 20% of US nonfederal hospitals. A causative organism was identifiable in 50.28% of all admissions (culture positive), and the rest were culture negative. TTC was identified in 10 746 (95% CI, 10 049--11 444) admissions during this period that comprised 0.15% of all severe sepsis admissions. There was a progressive increase in frequency of TTC from 0.02% in 2007 to 0.25% in 2013 (*P*\<0.001; Figure [2](#jah33510-fig-0002){ref-type="fig"}). Baseline clinical characteristics of patients with and without TTC in severe sepsis are summarized in Table [3](#jah33510-tbl-0003){ref-type="table"}. Mean (±SD) age was 65.6±14.6 versus 67.7±16.2 years (*P*\<0.001) in those with and without TTC. Frequency of female sex, ages between 45 and 79 years, and white race were more frequent in patients with TTC. Diagnosis of TTC with severe sepsis was more frequent in large‐sized and urban teaching hospitals. Patients with TTC had a higher frequency of a pre‐existing anxiety disorder and, during the acute event, more likely to develop respiratory, hepatic, and neurological dysfunction. TTC patients also had a greater incidence of septic shock and the need for mechanical ventilation and intra‐aortic balloon pumping. Diagnostic coronary angiography without the need for coronary interventions was performed in 32% of admissions with TTC, suggestive of the absence of obstructive coronary artery disease. Only 2% of admissions with severe sepsis without TTC received diagnostic coronary angiography.

![Trends of Takotsubo cardiomyopathy. Represented as estimated percentage of cases with 95% confidence interval; *P* value for trend: *P*\<0.001. TTC indicates Takotsubo cardiomyopathy.](JAH3-7-e009160-g002){#jah33510-fig-0002}

###### 

Baseline Characteristics of Severe Sepsis Patients With and Without TTC

  Characteristic                                                                 Severe Sepsis With TTC% (N=10 746)   Severe Sepsis Without TTC% (N=7 052 712)   *P* Value
  ------------------------------------------------------------------------------ ------------------------------------ ------------------------------------------ -----------
  Age group, y                                                                                                                                                   
  20 to 44                                                                       7.7                                  9.0                                        \<0.001
  45 to 64                                                                       35.9                                 30.1                                       
  65 to 79                                                                       38.6                                 33.2                                       
  ≥80 y                                                                          17.7                                 27.7                                       
  Sex                                                                                                                                                            
  Female                                                                         75.7                                 49.1                                       \<0.001
  Race                                                                                                                                                           
  White                                                                          77.9                                 69.5                                       \<0.001
  Black                                                                          8.0                                  15.4                                       
  Hispanic                                                                       7.5                                  8.9                                        
  Asian                                                                          3.2                                  2.7                                        
  Native American                                                                0.6                                  0.6                                        
  Others                                                                         2.7                                  2.7                                        
  Primary payer                                                                                                                                                  
  Medicare                                                                       62.5                                 66.6                                       0.003
  Medicaid                                                                       11.0                                 10.4                                       
  Private                                                                        19.8                                 17.0                                       
  Uninsured                                                                      3.8                                  3.3                                        
  No charge                                                                      0.3                                  0.3                                        
  Others                                                                         2.3                                  2.3                                        
  Hospital teaching status and location[a](#jah33510-note-0006){ref-type="fn"}                                                                                   
  Rural                                                                          4.7                                  9.7                                        \<0.001
  Urban nonteaching                                                              28.2                                 41.6                                       
  Urban teaching                                                                 67.1                                 48.7                                       
  Hospital bed size[a](#jah33510-note-0006){ref-type="fn"}                                                                                                       
  Small                                                                          8.7                                  10.9                                       0.003
  Medium                                                                         22.8                                 25.0                                       
  Large                                                                          68.5                                 64.1                                       
  Hospital volume[a](#jah33510-note-0006){ref-type="fn"}                                                                                                         
  Small                                                                          33.0                                 33.2                                       0.1
  Medium                                                                         36.9                                 34.2                                       
  Large                                                                          30.1                                 32.6                                       
  Hospital region[a](#jah33510-note-0006){ref-type="fn"}                                                                                                         
  Northeast                                                                      18.5                                 18.5                                       \<0.001
  Midwest                                                                        26.2                                 21.7                                       
  South                                                                          31.4                                 38.5                                       
  West                                                                           23.9                                 21.2                                       
  Charlson Comorbidity Index                                                                                                                                     
  0 to 3                                                                         72.3                                 71.7                                       0.001
  4 to 6                                                                         21.6                                 20.8                                       
  ≥7                                                                             6.0                                  7.5                                        
  Smoking history                                                                19.9                                 15.8                                       \<0.001
  Anxiety disorder                                                               7.0                                  4.3                                        \<0.001
  Hypertension                                                                   48.9                                 52.8                                       \<0.001
  Mechanical ventilation                                                         57.4                                 30.5                                       \<0.001
  Intra‐aortic balloon pumping                                                   4.7                                  0.4                                        \<0.001
  Angiography use                                                                32.4                                 2.1                                        \<0.001
  Septic shock                                                                   45.2                                 31.0                                       \<0.001
  Acute respiratory dysfunction[b](#jah33510-note-0007){ref-type="fn"}           75.2                                 48.5                                       \<0.001
  Acute cardiovascular dysfunction[b](#jah33510-note-0007){ref-type="fn"}        63.8                                 43.4                                       \<0.001
  Acute renal dysfunction[b](#jah33510-note-0007){ref-type="fn"}                 51.1                                 54.6                                       \<0.001
  Acute hepatic dysfunction[b](#jah33510-note-0007){ref-type="fn"}               9.3                                  5.5                                        \<0.001
  Acute hematological dysfunction[b](#jah33510-note-0007){ref-type="fn"}         19.0                                 18.6                                       0.6
  Acute neurological dysfunction[b](#jah33510-note-0007){ref-type="fn"}          24.7                                 20.1                                       \<0.001

All values are represented as percentage. NIS indicates National Inpatient Sample; TTC, Takotsubo cardiomyopathy.

Refer to text and the NIS database classification for details.

Refer to Table [2](#jah33510-tbl-0002){ref-type="table"} for acute organ dysfunction details.

Mortality and Morbidity Outcomes {#jah33510-sec-0014}
--------------------------------

Unadjusted in‐hospital mortality was not different between those with and without TTC (20.6% versus 22.3%; *P*=0.06; Table [4](#jah33510-tbl-0004){ref-type="table"}). After multivariable adjustment TTC patients had lower in‐hospital mortality (odds ratio \[OR\], 0.58; 95% CI, 0.51--0.65; *P*\<0.001; Table [5](#jah33510-tbl-0005){ref-type="table"}). This lower adjusted in‐hospital mortality was still observed when restricting cubic spline transformations of age and year of admission using 5 knots to model the nonlinear relationship with mortality and in the regression model (OR, 0.58; 95% CI, 0.51--0.66; *P*\<0.001) and using the propensity‐matched sample (OR, 0.52; 95% CI, 0.44--0.61; *P*\<0.001; [Table S1](#jah33510-sup-0001){ref-type="supplementary-material"}). Patients with TTC had a longer duration of hospitalization, higher hospitalization costs, and were more frequently to be discharged to a skilled nursing facility and home with home healthcare assistance as compared with those without TTC (Table [4](#jah33510-tbl-0004){ref-type="table"}).

###### 

Clinical Outcomes of TTC in Severe Sepsis

  Outcome                                     Severe Sepsis With TTC% (N=10 746)   Severe Sepsis Without TTC% (N=7 052 712)   *P* Value
  ------------------------------------------- ------------------------------------ ------------------------------------------ -----------
  In‐hospital mortality                       20.6                                 22.3                                       0.06
  Median length of stay, days                 12 (7--20)                           8 (4--15)                                  \<0.001
  Median hospitalization costs (US dollars)   115 625 (63 901--227 979)            57 652 (27 374--127 229)                   \<0.001
  Discharge disposition                                                                                                       
  Home                                        20.4                                 22.5                                       0.02
  Skilled nursing facility                    39.0                                 36.0                                       0.005
  Transferred to other hospitals              3.6                                  4.1                                        0.2
  Home with home health care                  15.7                                 14.2                                       0.03
  Against medical advice                      0.1                                  0.5                                        0.01
  Unknown                                     0.3                                  0.2                                        0.1

Represented as percentage or median (interquartile range). TTC indicates Takotsubo cardiomyopathy.

###### 

Multivariate Analysis for In‐Hospital Mortality in Severe Sepsis

  Characteristic                                                                 Odds Ratio                                               95% Confidence Interval   *P* Value   
  ------------------------------------------------------------------------------ -------------------------------------------------------- ------------------------- ----------- ---------
  Takotsubo cardiomyopathy                                                       0.58                                                     0.51                      0.65        \<0.001
  Age group, y                                                                                                                                                                  
  20 to 44                                                                       Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  45 to 64                                                                       1.48                                                     1.44                      1.51        \<0.001
  65 to 79                                                                       2.26                                                     2.19                      2.34        \<0.001
  ≥80 y                                                                          4.03                                                     3.90                      4.19        \<0.001
  Sex                                                                                                                                                                           
  Female                                                                         1.06                                                     1.05                      1.07        \<0.001
  Year of admission                                                                                                                                                             
  2007                                                                           Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  2008                                                                           0.95                                                     0.90                      1.00        0.09
  2009                                                                           0.79                                                     0.75                      0.84        \<0.001
  2010                                                                           0.71                                                     0.67                      0.75        \<0.001
  2011                                                                           0.63                                                     0.60                      0.68        \<0.001
  2012                                                                           0.51                                                     0.48                      0.53        \<0.001
  2013                                                                           0.47                                                     0.44                      0.49        \<0.001
  Race                                                                                                                                                                          
  White                                                                          Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  Black                                                                          1.05                                                     1.03                      1.07        \<0.001
  Hispanic                                                                       0.99                                                     0.96                      1.02        0.56
  Asian                                                                          1.03                                                     0.97                      1.08        0.35
  Native American                                                                0.96                                                     0.88                      1.04        0.29
  Others                                                                         0.98                                                     0.95                      1.03        0.46
  Primary payer                                                                                                                                                                 
  Medicare                                                                       Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  Medicaid                                                                       1.08                                                     1.05                      1.10        \<0.001
  Private                                                                        1.08                                                     1.05                      1.10        \<0.001
  Uninsured                                                                      1.30                                                     1.24                      1.36        \<0.001
  No charge                                                                      1.22                                                     1.08                      1.38        0.002
  Others                                                                         1.34                                                     1.25                      1.44        \<0.001
  Hospital teaching status and location[b](#jah33510-note-0011){ref-type="fn"}                                                                                                  
  Rural                                                                          Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  Urban nonteaching                                                              0.89                                                     0.85                      0.92        \<0.001
  Urban teaching                                                                 1.04                                                     0.99                      1.10        0.10
  Hospital bed size[b](#jah33510-note-0011){ref-type="fn"}                                                                                                                      
  Small                                                                          Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  Medium                                                                         1.04                                                     0.99                      1.09        0.09
  Large                                                                          1.15                                                     1.10                      1.20        \<0.001
  Hospital volume[b](#jah33510-note-0011){ref-type="fn"}                                                                                                                        
  Small                                                                          Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  Medium                                                                         0.90                                                     0.87                      0.93        \<0.001
  Large                                                                          0.79                                                     0.75                      0.82        \<0.001
  Hospital region[b](#jah33510-note-0011){ref-type="fn"}                                                                                                                        
  Northeast                                                                      Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  Midwest                                                                        0.68                                                     0.65                      0.72        \<0.001
  South                                                                          0.82                                                     0.79                      0.86        \<0.001
  West                                                                           0.78                                                     0.75                      0.82        \<0.001
  Charlson Comorbidity Index                                                                                                                                                    
  0 to 3                                                                         Reference group[a](#jah33510-note-0010){ref-type="fn"}                                         
  4 to 6                                                                         1.31                                                     1.29                      1.33        \<0.001
  ≥7                                                                             2.52                                                     2.47                      2.58        \<0.001
  Mechanical ventilation                                                         1.76                                                     1.72                      1.79        \<0.001
  Septic shock                                                                   1.34                                                     1.31                      1.36        \<0.001
  Culture negative sepsis                                                        1.74                                                     1.72                      1.76        \<0.001
  Acute respiratory dysfunction[c](#jah33510-note-0012){ref-type="fn"}           3.32                                                     3.27                      3.39        \<0.001
  Acute cardiovascular dysfunction[c](#jah33510-note-0012){ref-type="fn"}        2.0                                                      1.95                      2.04        \<0.001
  Acute renal dysfunction[c](#jah33510-note-0012){ref-type="fn"}                 1.33                                                     1.31                      1.35        \<0.001
  Acute hepatic dysfunction[c](#jah33510-note-0012){ref-type="fn"}               2.22                                                     2.17                      2.26        \<0.001
  Acute hematological dysfunction[c](#jah33510-note-0012){ref-type="fn"}         1.36                                                     1.34                      1.39        \<0.001
  Acute neurological dysfunction[c](#jah33510-note-0012){ref-type="fn"}          1.18                                                     1.16                      1.20        \<0.001

All values are represented as odds ratio (95% confidence interval).

The first category in variables with \>2 categories was used as a reference group to develop odds ratios for the remaining categories was has been labeled as "Reference group."

Refer to text and the NIS (National Inpatient Sample) database classification for details.

Refer to Table [2](#jah33510-tbl-0002){ref-type="table"} for acute organ dysfunction details.

There was a significant interaction between TTC and sex (*P*=0.02) for in‐hospital mortality, such that relative mortality was higher in males (OR, 0.69; 95% CI, 0.55--0.85) compared with (OR, 0.51; 95% CI, 0.44--0.59). Baseline characteristics and outcomes for TTC patients stratified by sex are summarized in Table [6](#jah33510-tbl-0006){ref-type="table"} and Figure [3](#jah33510-fig-0003){ref-type="fig"}. Male patients with TTC were significantly younger than females. Male patients had a higher Charlson Comorbidity Index and were more likely to require mechanical ventilation and develop multiorgan failure.

###### 

Baseline Characteristics and Outcomes of Male and Female Patients With Takotsubo Cardiomyopathy

  Baseline Characteristics and Outcomes                                          Male Sex % (N=2613)   Female Sex % (N=8133)   *P* Value
  ------------------------------------------------------------------------------ --------------------- ----------------------- -----------
  Baseline characteristics                                                                                                     
  Year of admission                                                                                                            
  2007                                                                           0.9                   2.2                     0.08
  2008                                                                           4.2                   5.7                     
  2009                                                                           7.6                   9.4                     
  2010                                                                           12.0                  13.6                    
  2011                                                                           18.5                  16.8                    
  2012                                                                           23.2                  23.9                    
  2013                                                                           33.7                  28.5                    
  Age group, y                                                                                                                 
  20 to 44                                                                       11.2                  6.7                     \<0.001
  45 to 64                                                                       41.3                  34.2                    
  65 to 79                                                                       34.7                  39.9                    
  ≥80                                                                            12.9                  19.2                    
  Race                                                                                                                         
  White                                                                          74.0                  79.2                    0.11
  Black                                                                          8.8                   7.7                     
  Hispanic                                                                       9.2                   6.7                     
  Asian                                                                          4.3                   2.8                     
  Native American                                                                0.2                   0.8                     
  Other                                                                          3.4                   2.5                     
  Primary payer                                                                                                                
  Medicare                                                                       56.5                  64.4                    0.004
  Medicaid                                                                       10.0                  11.4                    
  Private                                                                        24.7                  18.2                    
  Uninsured                                                                      5.2                   3.4                     
  No charge                                                                      0.4                   0.3                     
  Others                                                                         3.2                   2.3                     
  Hospital teaching status and location[a](#jah33510-note-0014){ref-type="fn"}                                                 
  Rural                                                                          3.6                   5.1                     \<0.001
  Urban nonteaching                                                              21.7                  30.3                    
  Urban teaching                                                                 74.8                  64.6                    
  Hospital bed size[a](#jah33510-note-0014){ref-type="fn"}                                                                     
  Small                                                                          9.0                   8.6                     0.29
  Medium                                                                         20.3                  23.5                    
  Large                                                                          70.7                  67.9                    
  Hospital volume[a](#jah33510-note-0014){ref-type="fn"}                                                                       
  Small                                                                          30.1                  33.9                    0.17
  Medium                                                                         40.1                  35.9                    
  Large                                                                          29.8                  30.2                    
  Hospital region[a](#jah33510-note-0014){ref-type="fn"}                                                                       
  Northeast                                                                      18.5                  18.5                    0.97
  Midwest                                                                        26.9                  25.9                    
  South                                                                          31.4                  31.4                    
  West                                                                           23.2                  24.2                    
  Charlson Comorbidity Index                                                                                                   
  0 to 3                                                                         68.8                  72.5                    0.01
  4 to 6                                                                         24.1                  20.8                    
  ≥7                                                                             7.1                   5.7                     
  Smoking history                                                                22.0                  19.3                    0.18
  Anxiety disorder                                                               5.1                   7.6                     0.05
  Hypertension                                                                   45.9                  49.8                    0.11
  Mechanical ventilation                                                         62.7                  55.7                    0.006
  Septic shock                                                                   48.9                  44.0                    0.06
  Acute respiratory dysfunction[b](#jah33510-note-0015){ref-type="fn"}           78.5                  74.2                    0.05
  Acute cardiovascular dysfunction[b](#jah33510-note-0015){ref-type="fn"}        68.1                  62.5                    0.02
  Acute renal dysfunction[b](#jah33510-note-0015){ref-type="fn"}                 56.5                  49.4                    0.005
  Acute hepatic dysfunction[b](#jah33510-note-0015){ref-type="fn"}               9.4                   9.4                     0.99
  Acute hematological dysfunction[b](#jah33510-note-0015){ref-type="fn"}         22.0                  18.0                    0.04
  Acute neurological dysfunction[b](#jah33510-note-0015){ref-type="fn"}          23.5                  25.1                    0.43
  Outcomes                                                                                                                     
  In‐hospital mortality                                                          23.6                  19.7                    0.05
  Discharge disposition                                                                                                        
  Home                                                                           21.3                  20.1                    0.54
  Skilled nursing facility                                                       35.7                  40.1                    0.07
  Transferred to other hospitals                                                 4.8                   3.3                     0.11
  Home with home health care                                                     14.1                  16.2                    0.26
  Against medical advice                                                         0.0                   0.3                     0.25
  Unknown                                                                        0.4                   0.4                     0.97

All values are represented as percentage.

Refer to text and the NIS (National Inpatient Sample) database classification for details.

Refer to Table [2](#jah33510-tbl-0002){ref-type="table"} for acute organ dysfunction details.

![Age distribution for male and female patients with Takotsubo cardiomyopathy complicating severe sepsis. TTC indicates Takotsubo cardiomyopathy.](JAH3-7-e009160-g003){#jah33510-fig-0003}

Predictors of Development and Mortality in TTC {#jah33510-sec-0015}
----------------------------------------------

In an exploratory analysis in admissions with TTC, multivariate logistic regression analysis was used to evaluate predictors of development of TTC and mortality in admissions with TTC (Table [7](#jah33510-tbl-0007){ref-type="table"}). Baseline characteristics and comorbidities were used to evaluate predictors of the development of TTC. Presentation in later years of the study period, middle aged (45--79 years), female sex, and white race were independent predictors for the diagnosis of TTC in severe sepsis. In severe sepsis admissions with TTC, age ≥80 years, black race, greater comorbidity, and multiorgan dysfunction were independently associated with in‐hospital mortality (Table [7](#jah33510-tbl-0007){ref-type="table"}).

###### 

Multivariable Predictors of Development of and Mortality in TTC

  Parameter                                                                      Incidence of TTC (N=10 746)                              Mortality in TTC (N=2214)                    
  ------------------------------------------------------------------------------ -------------------------------------------------------- --------------------------- ---------------- ---------
  Year of admission                                                                                                                                                                    
  2007                                                                           Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  2008                                                                           2.2 (1.4--3.6)                                           0.002                       2.2 (0.8--6.4)   0.13
  2009                                                                           3.6 (2.2--5.8)                                           \<0.001                     1.6 (0.6--4.4)   0.37
  2010                                                                           5.2 (3.3--8.1)                                           \<0.001                     1.5 (0.6--3.9)   0.43
  2011                                                                           6.0 (3.9--9.3)                                           \<0.001                     1.3 (0.5--3.3)   0.63
  2012                                                                           8.5 (5.4--13.5)                                          \<0.001                     1.1 (0.4--2.8)   0.88
  2013                                                                           9.3 (6.0--14.4)                                          \<0.001                     1.0 (0.4--2.6)   0.98
  Age group, y                                                                                                                                                                         
  20 to 44                                                                       Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  45 to 64                                                                       1.4 (1.2--1.7)                                           \<0.001                     1.4 (0.8--2.4)   0.19
  65 to 79                                                                       1.6 (1.3--1.9)                                           \<0.001                     1.8 (1.1--3.3)   0.04
  ≥80                                                                            0.9 (0.7--1.2)                                           0.41                        2.9 (1.6--5.6)   0.001
  Sex                                                                                                                                                                                  
  Female                                                                         3.6 (3.2--4.0)                                           \<0.001                     0.8 (0.6--1.1)   0.10
  Race                                                                                                                                                                                 
  White                                                                          Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  Black                                                                          0.4 (0.3--0.5)                                           \<0.001                     1.6 (1.1--2.4)   0.03
  Hispanic                                                                       0.7 (0.6--0.8)                                           \<0.001                     1.4 (0.9--2.1)   0.15
  Asian                                                                          0.9 (0.7--1.2)                                           0.39                        0.6 (0.3--1.4)   0.21
  Native American                                                                0.7 (0.4--1.3)                                           0.30                        0.7 (0.2--3.4)   0.65
  Other                                                                          0.7 (0.6--0.9)                                           0.04                        1.7 (0.9--3.3)   0.11
  Primary payer                                                                                                                                                                        
  Medicare                                                                       Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  Medicaid                                                                       1.1 (0.9--1.3)                                           0.41                        1.1 (0.7--1.7)   0.76
  Private                                                                        1.1 (1.0--1.3)                                           0.13                        0.9 (0.6--1.2)   0.46
  Uninsured                                                                      1.3 (1.1--1.6)                                           0.03                        0.9 (0.5--1.9)   0.98
  No charge                                                                      1.1 (0.5--2.4)                                           0.86                        1.7 (0.3--8.9)   0.55
  Others                                                                         1.2 (0.9--1.6)                                           0.22                        0.3 (0.1--1.1)   0.08
  Hospital teaching status and location[b](#jah33510-note-0018){ref-type="fn"}                                                                                                         
  Rural                                                                          Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  Urban nonteaching                                                              1.2 (0.9--1.6)                                           0.16                        0.7 (0.4--1.3)   0.27
  Urban teaching                                                                 2.2 (1.7--3.0)                                           \<0.001                     1.0 (0.6--1.8)   0.92
  Hospital bed size[b](#jah33510-note-0018){ref-type="fn"}                                                                                                                             
  Small                                                                          Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  Medium                                                                         1.1 (0.9--1.4)                                           0.36                        1.1 (0.7--1.8)   0.66
  Large                                                                          1.3 (1.0--1.6)                                           0.05                        1.2 (0.7--1.9)   0.53
  Hospital volume[b](#jah33510-note-0018){ref-type="fn"}                                                                                                                               
  Small                                                                          Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  Medium                                                                         1.2 (1.1--1.5)                                           0.01                        0.8 (0.6--1.1)   0.21
  Large                                                                          1.1 (0.8--1.5)                                           0.59                        0.7 (0.4--1.2)   0.16
  Hospital region[b](#jah33510-note-0018){ref-type="fn"}                                                                                                                               
  Northeast                                                                      Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  Midwest                                                                        1.1 (0.9--1.3)                                           0.53                        0.8 (0.6--1.1)   0.22
  South                                                                          0.9 (0.8--1.1)                                           0.17                        0.9 (0.7--1.3)   0.57
  West                                                                           1.3 (1.1--1.5)                                           0.003                       0.9 (0.6--1.3)   0.66
  Charlson Comorbidity Index                                                                                                                                                           
  0 to 3                                                                         Reference group[a](#jah33510-note-0017){ref-type="fn"}                                                
  4 to 6                                                                         1.0 (0.9--1.2)                                           0.54                        1.3 (0.9--1.7)   0.07
  ≥7                                                                             0.9 (0.8--0.9)                                           0.02                        1.6 (1.1--2.5)   0.03
  Mechanical ventilation                                                         ···                                                      ···                         1.5 (1.1--2.2)   0.02
  Septic shock                                                                   ···                                                      ···                         1.1 (0.8--1.5)   0.62
  Acute respiratory dysfunction[c](#jah33510-note-0019){ref-type="fn"}           ···                                                      ···                         2.3 (1.5--3.5)   \<0.001
  Acute cardiovascular dysfunction[c](#jah33510-note-0019){ref-type="fn"}        ···                                                      ···                         1.9 (1.4--2.7)   \<0.001
  Acute renal dysfunction[c](#jah33510-note-0019){ref-type="fn"}                 ···                                                      ···                         1.3 (0.9--1.6)   0.09
  Acute hepatic dysfunction[c](#jah33510-note-0019){ref-type="fn"}               ···                                                      ···                         1.7 (1.2--2.5)   0.003
  Acute hematological dysfunction[c](#jah33510-note-0019){ref-type="fn"}         ···                                                      ···                         1.4 (1.1--1.9)   0.02
  Acute neurological dysfunction[c](#jah33510-note-0019){ref-type="fn"}          ···                                                      ···                         1.2 (0.9--1.6)   0.13

All values are represented as odds ratio (95% confidence interval). CI indicates confidence interval; OR, odds ratio; TTC, Takotsubo cardiomyopathy.

The first category in variables with \>2 categories was used as a reference group to develop odds ratios for the remaining categories was has been labeled as "Reference group."

Refer to text and the NIS (National Inpatient Sample) database classification for details.

Refer to Table [2](#jah33510-tbl-0002){ref-type="table"} for acute organ dysfunction details.

Discussion {#jah33510-sec-0016}
==========

To the best of our knowledge, this is the first large‐scale study evaluating the epidemiology of TTC in severe sepsis. TTC comprised 0.15% of the total admissions with severe sepsis, with a steady increase in frequency from 0.02% in 2007 to 0.25% in 2013. Severe sepsis admissions with TTC were frequent in middle‐aged females and had higher severity of illness. In this cohort of severe sepsis, a diagnosis of TTC was associated with a significantly lower in‐hospital mortality compared with patients without TTC, being more prominent in females.

Epidemiology of TTC {#jah33510-sec-0017}
-------------------

Sepsis has long been known to be a trigger for TTC. In a previous study using the NIS database, El‐Sayed et al noted 7% of TTC cases to be associated with sepsis.[25](#jah33510-bib-0025){ref-type="ref"} In a Japanese database of 3747 TTC patients, 2.8% of the cases were noted to be associated with sepsis.[26](#jah33510-bib-0026){ref-type="ref"} In a recent systematic review, Cappelletti et al documented 26 published cases of TTC in septic patients.[27](#jah33510-bib-0027){ref-type="ref"} These data highlight the current paucity of data on the epidemiology of TTC in sepsis and clinical outcomes. Using validated *ICD‐9‐CM* algorithms, this study addresses the knowledge gap in epidemiology and outcomes of TTC in sepsis.[25](#jah33510-bib-0025){ref-type="ref"}, [28](#jah33510-bib-0028){ref-type="ref"} Templin et al, in a multinational registry of 1750 patients, noted 90% of TTC patients to be women, with 79% being aged \>50 years.[1](#jah33510-bib-0001){ref-type="ref"} Our study in severe sepsis patients is consistent with respect to age, with 92% patients being aged \>45 years. However, a notable difference was a lower incidence of female sex with only 76% being women. The lower frequency of women with TTC in this study compared with other epidemiological data can be explained by the differences in epidemiology of severe sepsis, given that nearly 50% of all patients with severe sepsis are women.[28](#jah33510-bib-0028){ref-type="ref"} Potentially, differences in the nature of the triggering event may also account for this difference. A physical trigger was present in only 36% of the Templin et al study, whereas severe sepsis and the processes of care in the intensive care unit served as potential physical triggers for our entire study population.

Frequency of TTC steadily increased from 2007 to 2013 in this nationally representative population. This can be explained by multiple hypotheses. First, this study duration coincided with the evolution of point‐of‐care cardiac ultrasonography in critical illness, resulting in the higher application and likely greater diagnosis of TTC at the bedside.[29](#jah33510-bib-0029){ref-type="ref"} Second, the initial TTC criteria were proposed in 2004 with a subsequent revision in 2008 that potentially resulted in the further unification of clinical definitions and higher awareness in treating physicians.[2](#jah33510-bib-0002){ref-type="ref"}, [5](#jah33510-bib-0005){ref-type="ref"} The first reported series of TTC in sepsis was in 2005, providing additional awareness.[30](#jah33510-bib-0030){ref-type="ref"} Third, there has been a growing interest in cardiovascular outcomes in sepsis in recent years, potentially influencing clinical diagnostic and management pathways.[9](#jah33510-bib-0009){ref-type="ref"}, [11](#jah33510-bib-0011){ref-type="ref"}, [12](#jah33510-bib-0012){ref-type="ref"} Finally, epidemiology of sepsis has changed over these years, likely reflecting an increase in illness severity and thereby triggering higher rates of TTC.[21](#jah33510-bib-0021){ref-type="ref"}

Mortality With TTC in Severe Sepsis {#jah33510-sec-0018}
-----------------------------------

Whereas unadjusted mortality in the 2 groups was not different, we observed lower adjusted mortality in septic patients with TTC (OR, 0.58). In the a priori designed multivariate analysis using clinical and statistically relevant covariates, we noted that adjusting for sepsis and mechanical ventilation had the highest influence on mortality. This may be attributed to several factors. TTC patients were younger, more likely to be admitted to large‐volume teaching hospitals, and had lower baseline comorbidity, characteristics associated with better survival.[31](#jah33510-bib-0031){ref-type="ref"} In the United States, absolute mortality from TTC is much higher in patients with sepsis (20.6% in this study) than other patient types with TTC (4%).[32](#jah33510-bib-0032){ref-type="ref"} In an unselected critical ill population, mortality was 15%, which is similar to that noted in this cohort of severe sepsis patients.[33](#jah33510-bib-0033){ref-type="ref"} This interaction between sepsis and TTC is worthy of further mechanistic studies, similar to previous literature on septic cardiomyopathy.[34](#jah33510-bib-0034){ref-type="ref"} TTC shares many common attributes with septic cardiomyopathy, and one can speculate that it may share similar mechanisms and confer survival advantage in left ventricular systolic dysfunction in sepsis.[35](#jah33510-bib-0035){ref-type="ref"} Conversely, the lower mortality in TTC patients may have occurred because of ascertainment bias given that the sickest septic patients with TTC may have died before a diagnosis was made.

An important observation is the differences in characteristics for males and females with TTC in this study. Despite being predominantly a disease of female sex, there was higher frequency of males, and males were younger but with higher comorbidities. Consistent with other studies, we showed higher severity of illness and a trend toward worse outcomes in males as compared with females with severe sepsis.[36](#jah33510-bib-0036){ref-type="ref"}, [37](#jah33510-bib-0037){ref-type="ref"} Importantly, this study noted improving mortality in patients with TTC with every subsequent year during the study period. This could be explained by multiple hypothesis: (1) With a greater understanding of sepsis pathophysiology, there has been a shift away from elements of the early goal‐directed therapy, such as blood transfusions and inotropes, that may adversely affect mortality[38](#jah33510-bib-0038){ref-type="ref"}, [39](#jah33510-bib-0039){ref-type="ref"}; (2) greater emphasis on cardiovascular outcomes in sepsis and use of bedside point‐of‐care ultrasonography in critical care[11](#jah33510-bib-0011){ref-type="ref"}, [12](#jah33510-bib-0012){ref-type="ref"}; and (3) evolution in the diagnosis and management of TTC since the unifying criteria were published in 2005.[5](#jah33510-bib-0005){ref-type="ref"} Alternately, as with other administrative databases, this could potentially represent potential overdiagnoses resulting in decreased severity of illness of included patients.

Limitations {#jah33510-sec-0019}
-----------

This study has certain important limitations. Use of an administrative database and *ICD‐9‐CM* codes is associated with selection and informational biases. However, the previous validation of these *ICD‐9‐CM* codes partially mitigates these shortcomings.[21](#jah33510-bib-0021){ref-type="ref"} The lack of detailed echocardiographic and coronary angiography data that are used to define TTC can result in significant overlap with septic cardiomyopathy. However, the dramatic "apical ballooning" observed in TTC and the global left ventricular systolic dysfunction of septic cardiomyopathy are readily distinguishable on echocardiography.[11](#jah33510-bib-0011){ref-type="ref"}, [12](#jah33510-bib-0012){ref-type="ref"} Additionally, coronary angiography is infrequently performed (≈5%) in septic patients because of concomitant hemodynamic instability and kidney injury.[40](#jah33510-bib-0040){ref-type="ref"} It is possible that the increasing incidence of TTC could reflect a greater diagnosis and awareness, as highlighted in the discussion previously, but alternately could represent a false‐positive diagnosis. However, our data are consistent with national trends of both primary and secondary diagnosis of TTC from other groups, making a false‐positive diagnosis less likely.[41](#jah33510-bib-0041){ref-type="ref"} Our data sources did not allow us to capture processes of care---especially intravenous fluid therapy, vasopressor and inotrope use, and extent of positive pressure used in mechanical ventilation---all of which could potentially influence the development or worsening of TTC. The recent iteration of the NIS database after its redesign in 2012 limits volume assessments both at hospital and state level.[42](#jah33510-bib-0042){ref-type="ref"} Because the NIS data are limited to duration of hospital stay, we are unable to comment on the long‐term outcomes, including recovery of ventricular function, in this cohort. The absence of detailed echocardiographic data prevents us from evaluating the occurrence of nonapical variants of TTC in this population.

Conclusions {#jah33510-sec-0020}
===========

In conclusion, despite the inherent limitations of the study, it provides novel insights into the evolving epidemiology and outcomes of TTC in severe sepsis. TTC is observed with increasing frequency in patients with severe sepsis and was associated with a significantly lower in‐hospital mortality compared with patients without TTC. Presentation in later years of the study period, middle age, female sex, and white race were independent predictors for the diagnosis of TTC in severe sepsis. Further dedicated studies evaluating the pathophysiology, clinical implications, and diagnosis of TTC in severe sepsis and septic shock are needed to optimize management and outcomes in these patients.
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**Table S1.** Multivariate Analysis for In‐Hospital Mortality in Severe Sepsis (Restricted Cubic Spline Analysis)

###### 

Click here for additional data file.
